Neostigmine Methylsulfate Injection
Product Images NDC 71839-105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 71839-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neo10mgcarton10

Neo10mgcarton10
Neostigmine Methylsulfate Injection, USP is a medication available in a 10mL bottle for intravenous use. The concentration of the injection is at 1 mg/mL.*
FDA Label Image

Neo10mgcartonlabel

Neo10mgcartonlabel
This is a medication called Neostigmine Methylsulfate Injection, USP. It is a 10mg/10mL solution (1mg/mL) for intravenous use, packaged in a 10mL vial. Each mL contains Neostigmine Methylsulfate 1mg, Phenol 4.5mg (used as a preservative), Sodium Acetate Trihydrate 0.2mg, Water for Injection, pH adjusted, when necessary, with Sodium Hydroxide/Acetic Acid. The vial stopper is not made with natural rubber latex. Directions for use are included with the package insert. It should be stored at 20 degrees to 25 degrees Celsius (68 degrees to 77 degrees Fahrenheit), and should be protected from light. The medication is distributed by BE Pharmaceuticals Inc. and made in India.*
FDA Label Image

Neo10mgoutercartonlabel

Neo10mgoutercartonlabel
Neostigmine Methylsulfate Injection is a medication for intravenous use. It comes in 24 multipack dose vials of 10 mL each, containing 1 mg/mL of the active ingredient. The product code is £0910002.*
FDA Label Image

Neo10mgviallabel

Neo10mgviallabel
This text is a mixture of alphanumeric characters and symbols that do not make sense. The only useful pieces of information that can be gathered are an address (203 New Edition Court, Cary, NC 275) and a product name (Neostigmine Methylsulfate Injection). The other text appears to be a combination of IDs, batch numbers, and codes that are not useful as they are unreadable.*
FDA Label Image

Neo5mgcarton10

Neo5mgcarton10
Neostigmine Methylsulfate Injection, USP is a medication for intravenous use. It comes in a 10 x 10 mL multiple dose vial containing 0.5 mg/mL of the active ingredient. The drug's NDC number is 71839-105-10. The temperature range for storage is 15-30°C, and it must be protected from light. The rest of the text is not legible.*
FDA Label Image

Neo5mgcartonlabel

Neo5mgcartonlabel
This is a set of labels of Neostigmine Methylsulfate Injection in 10 mL multiple dose vials with a concentration of 0.5 mg/ml and 5 mg/ml. The label provides information on dosage, administration, storage instructions, and manufacturer details.*
FDA Label Image

Neo5mgoutercartonlabel

Neo5mgoutercartonlabel
This is a pharmaceutical product information for Neostigmine Methylsulfate Injection, USP. The injection is intended for intravenous use and is available in a multipack of 24 vials, each containing 10 mL of solution with a concentration of 0.5 mg/mL. The product is identified with the lot number T10524.*
FDA Label Image

Neo5mgviallabel

Neo5mgviallabel
This text appears to be a description of a pharmaceutical product. It includes a lot number, address, and contact information for the distributor, and lists the drug's name, active ingredient, strength, and recommended use. It appears to be a 10mL vial of Neostigmine for intravenous use, containing 0.5 mg/mL of Methylsulfate, and made in India. The product is labeled with a warning that it is Rx-only (prescription required), and it appears the label includes a barcode as well.*
FDA Label Image
FDA Label Image

Neostr (Neostr)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.